The Official Journal of the European Society of Pathology

Mission statement: To advance the scientific basis of human pathology by the publication (encouragement and dissemination) of high quality research (including molecular and translational studies) and thereby contribute to patient care.

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.

98% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Daniela Massi
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.535 (2021)
Impact factor
4.161 (2021)
Five year impact factor
17 days
Submission to first decision (Median)
624,640 (2021)
Downloads

Latest articles

Journal updates

  • Virtual Collection 2021 : Uropathology

    Explore highlight content from Virchows Archiv and Modern Pathology in this joint virtual collection on Uropathology

    Uropathology Image virtual collection
  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Pancreatobiliary Neoplasms: Virtual Collection

    Explore highlight content from across Virchows Archiv and Modern Pathology in this joint virtual collection.

    Pancreatobiliary Neoplasms image
  • Annual Review Issue 2019: Cancer immunology, inflammation and tolerance

    The 2019 Annual Review Issue focuses on preclinical and clinical advances through which immunotherapy came of age. It calls upon a group of experts who are leading authorities in their respective fields to produce cutting-edge review articles.

    Annual Review Issue 2019 Teaser image
View all updates

Societies, partners and affiliations

About this journal

Electronic ISSN
1432-2307
Print ISSN
0945-6317
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Current Contents/ Life Sciences
  12. Dimensions
  13. EBSCO Biomedical Reference Collection
  14. EBSCO CINAHL
  15. EBSCO Discovery Service
  16. EMBASE
  17. Google Scholar
  18. Japanese Science and Technology Agency (JST)
  19. Journal Citation Reports/Science Edition
  20. Medline
  21. Naver
  22. Norwegian Register for Scientific Journals and Series
  23. OCLC WorldCat Discovery Service
  24. Pathway Studio
  25. Portico
  26. ProQuest-ExLibris Primo
  27. ProQuest-ExLibris Summon
  28. Reaxys
  29. SCImago
  30. SCOPUS
  31. Science Citation Index
  32. Science Citation Index Expanded (SCIE)
  33. Semantic Scholar
  34. TD Net Discovery Service
  35. UGC-CARE List (India)
  36. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer-Verlag GmbH Germany, part of Springer Nature